Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette G Beck-Sickinger

Showing results (301-310 of 310) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 310 results.
The Journal of Experimental Medicine|June 4, 2008
Sialyltransferase ST3Gal-IV controls CXCR2-mediated firm leukocyte arrest during inflammationDavid Frommhold, Andreas Ludwig, M Gabriele Bixel, et al.
Endocrinology|September 2, 2016
Effects of Peripheral Neurotensin on Appetite Regulation and Its Role in Gastric Bypass SurgeryCecilia Ratner, Louise J Skov, Zindy Raida, et al.
The American Journal of Pathology|August 26, 2011
A novel type of macrothrombocytopenia associated with a defect in α2,3-sialylationClaire Jones, Jonas Denecke, Ronald Sträter, et al.
Cell Research|September 25, 2021
Structures of active melanocortin-4 receptor-Gs-protein complexes with NDP-α-MSH and setmelanotideNicolas A Heyder, Gunnar Kleinau, David Speck, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 1, 2021
Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challengesCarmine Zoccali, Alberto Ortiz, Inga Arune Blumbyte, et al.
Nature|April 20, 2018
Structural basis of ligand binding modes at the neuropeptide Y Y<sub>1</sub> receptorZhenlin Yang, Shuo Han, Max Keller, et al.
Journal of Medicinal Chemistry|June 25, 2024
Development of a Potent and Selective G2A (GPR132) AgonistVictor Hernandez-Olmos, Jan Heering, Beatrice Marinescu, et al.
Journal of Medicinal Chemistry|July 1, 2020
A Venomics Approach Coupled to High-Throughput Toxin Production Strategies Identifies the First Venom-Derived Melanocortin Receptor AgonistsSteve Reynaud, Justyna Ciolek, Michel Degueldre, et al.
British Journal of Pharmacology|December 20, 2023
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptorsStephen P H Alexander, Arthur Christopoulos, Anthony P Davenport, et al.
British Journal of Pharmacology|December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptorsStephen P H Alexander, Anthony P Davenport, Eamonn Kelly, et al.
Pageof 31

Showing results (301-310 of 310) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 310 results.
The Journal of Experimental Medicine|June 4, 2008
Sialyltransferase ST3Gal-IV controls CXCR2-mediated firm leukocyte arrest during inflammationDavid Frommhold, Andreas Ludwig, M Gabriele Bixel, et al.
Endocrinology|September 2, 2016
Effects of Peripheral Neurotensin on Appetite Regulation and Its Role in Gastric Bypass SurgeryCecilia Ratner, Louise J Skov, Zindy Raida, et al.
The American Journal of Pathology|August 26, 2011
A novel type of macrothrombocytopenia associated with a defect in α2,3-sialylationClaire Jones, Jonas Denecke, Ronald Sträter, et al.
Cell Research|September 25, 2021
Structures of active melanocortin-4 receptor-Gs-protein complexes with NDP-α-MSH and setmelanotideNicolas A Heyder, Gunnar Kleinau, David Speck, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 1, 2021
Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challengesCarmine Zoccali, Alberto Ortiz, Inga Arune Blumbyte, et al.
Nature|April 20, 2018
Structural basis of ligand binding modes at the neuropeptide Y Y<sub>1</sub> receptorZhenlin Yang, Shuo Han, Max Keller, et al.
Journal of Medicinal Chemistry|June 25, 2024
Development of a Potent and Selective G2A (GPR132) AgonistVictor Hernandez-Olmos, Jan Heering, Beatrice Marinescu, et al.
Journal of Medicinal Chemistry|July 1, 2020
A Venomics Approach Coupled to High-Throughput Toxin Production Strategies Identifies the First Venom-Derived Melanocortin Receptor AgonistsSteve Reynaud, Justyna Ciolek, Michel Degueldre, et al.
British Journal of Pharmacology|December 20, 2023
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptorsStephen P H Alexander, Arthur Christopoulos, Anthony P Davenport, et al.
British Journal of Pharmacology|December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptorsStephen P H Alexander, Anthony P Davenport, Eamonn Kelly, et al.
Pageof 31